Bio-Plex 200 (Allergens)
Forecast Overview
- NAICS
- 541990
- Performance end
- 9/2026
This funding supports the procurement of a Bio-Plex multiplex system that serves as the essential instrumentation platform for the xMAP Food Allergen Detection Assay (xMAP FADA), an advanced multiplex immunoassay developed by FDA to simultaneously detect multiple food allergens, including gluten, in a single analytical test. This procurement is critical for replacing existing instrumentation that has approached the end of its operational reliability, ensuring continued support for ongoing method development and validation studies.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31
Related Federal Entities
- Department of Health and Human Services
- DarkStar - Laboratory Document Processing & Admin Support
- QE-HF replacement - Proteomics and Non-targeted Analysis
- Cyprotex Contract - Development of a 2D Human Neural Network Formation Assay (To
- New ORISE contractor/VSG Contractor
- Sciex OS Software Upgrades (Contaminants, Dietary Supplements, Nutrients)
- Federal Technology Spending Map
- Federal Opportunity Research